SecBot SecBot
6-K ·Filed May 18, 2026

AZN

ASTRAZENECA PLC
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago SEC0001654954-26-005049
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine vesting disclosure with no trading signal. Monitor for any subsequent open-market sales by Soriot, which would be separately reported. No immediate action warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$183.91
T+0 close · May 18, 2026 · via day close
Latest settled
−14.01%
T+60 · $158.14
Vs SPY
−18.59%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 18 $183.91entry
  2. T+1 · 6mo ago +0.42%α +1.07% · $184.68
  3. T+5 · 6mo ago +1.74%α +0.12% · $187.11
  4. T+20 · 5mo ago −3.61%α −5.80% · $177.27
  5. T+60 · 3mo ago −14.01%α −18.59% · $158.14

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

AstraZeneca filed a 6-K reporting the vesting of a performance share award to CEO Pascal Soriot on 14 May 2026. The award, granted in 2021 under the AstraZeneca Performance Share Plan, vested at 88% of target after a three-year performance period and two-year holding period, with 18,359 shares acquired for nil consideration. This is a routine executive compensation disclosure with no material financial or operational impact.

Key Facts

  • CEO Pascal Soriot received 18,359 ordinary shares upon vesting of a 2021 AZPSP award on 14 May 2026.
  • The award vested at 88% of target after a three-year performance period and two-year holding period.
  • Shares were acquired for nil consideration; 13,766 pence per share was the fair market value for tax purposes.
  • The filing is a routine PDMR shareholding disclosure with no new business or financial information.

Financial Impact

No material financial impact. The vesting involves 18,359 shares at a tax reference value of 13,766 pence each, but no cash consideration changed hands.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (36 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-005049
Document: 0001654954-26-005049-index-headers.html0001654954-26-005049
Document: 0001654954-26-005049-index.html0001654954-26-005049
Document: 0001654954-26-005049.txt0001654954-26-005049

Track record

77 reports on AZN

Performance horizon

19 of 38 bullish or bearish reports moved the stock their way by T+5. Best: +20.72% at T+60 after the Aug 17, 2026 report. 29 of 38 went positive at some point.

Filters
  1. Nov 16, 2026today 6-K Bullish 6/10 Entry price pending
  2. Nov 16, 2026today 6-K Bullish 6/10 Entry $185.55 Now $184.45 −0.59% settles Nov 23
  3. Nov 16, 2026today 6-K Bullish 6/10 Entry $185.31 Now $184.45 −0.46% settles Nov 23
  4. Nov 16, 2026today 6-K Bullish 5/10 Entry $185.09 Now $184.45 −0.35% settles Nov 23
  5. Nov 4, 202612d ago Institutional Cluster Mixed 3/10 Entry $186.85 to $184.38 Now $184.45 −1.28% ▼ −1.32% −4.61% vs SPY
  6. Nov 2, 202614d ago 6-K Neutral 1/10 Entry $186.58 to $189.39 Now $184.45 −1.14% ▲ +1.51% +1.43% vs SPY
  7. Nov 2, 202614d ago 6-K Neutral 1/10 Entry $186.58 to $189.39 Now $184.45 −1.14% ▲ +1.51% +1.43% vs SPY
  8. Oct 30, 202617d ago 6-K Neutral 5/10 Entry $186.65 to $186.43 Now $184.45 −1.18% ▼ −0.12% +2.59% vs SPY
  9. Oct 27, 202620d ago 6-K Bullish 5/10 Entry $170.08 to $183.88 Now $184.45 +8.45% ▲ +8.11% +10.10% vs SPY
  10. Oct 22, 202625d ago 6-K Bullish 6/10 Entry $172.57 to $173.46 Now $184.45 +6.88% ▲ +0.51% −0.19% vs SPY
Showing 10 of 77

US Market Status

Market Closed · Opens Wed (12h 3m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 18, 2026